Artonic
Advertising Networks · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1440 W Chicago Blvd 1100, Tecumseh, Mich...Phone Number
(517) 902-7851Website
www.artonicweb.comRevenue
<$5 MillionIndustry
About Artonic
Artonic Org Chart
Is Artonic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Artonic
Product Launch: Get notified when Artonic launches new products
Check if Artonic has recently received funding, and reach out quickly before it becomes old news!
Click to see if Artonic had a recent Job posting/layoffs
Earning: See what the market has to say on Artonic recently announced quarterly report
Funding: Get notified immidiatlly once Artonic has new funding data
Check out if Artonic is spiking on competitors!
Website visits: Recent activity has been detected on your website
Artonic, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Artonic
Compare insights from companies similar to Artonic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Artonic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Artonic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Artonic.
Artonic financials insights
Gather financial insights about Artonic, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$116K
Artonic Tech Stack
A closer look at the technologies used by Artonic
Artonic News & Media
Gemphire Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
LIVONIA, Mich., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and nonalcoholic steatohepatitis (NASH), today announced financial results for the quarter and nine months ended September 30, 2018, and provided a corporate update. “During the third quarter we had several accomplishments that are important to the continuedGemphire Therapeutics Announces Workforce Reduction
LIVONIA, Mich., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and nonalcoholic steatohepatitis (NASH), announces today that its Board of Directors has approved a workforce reduction in order to reduce costs and conserve cash resources. This decision was made in light of the previously announced request by the Food andGemphire Therapeutics Announces Workforce Reduction
LIVONIA, Mich., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and nonalcoholic steatohepatitis (NASH), announces today that its Board of Directors has approved a workforce reduction in order to reduce costs and conserve cash resources. This decision was made in light of the previously announced request by the Food andGemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
LIVONIA, Mich., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and nonalcoholic steatohepatitis (NASH), today announced financial results for the quarter and six months ended June 30, 2018, and provided a corporate update. “We capped off our second quarter by announcing that our INDIGO-1 trial investigating gemcabene in
Top Advertising Networks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Artonic
Artonic is a Michigan-based web design and digital marketing agency that specializes in creating visually appealing websites and enhancing lead generation for businesses. Their services include website development, search engine optimization, pay-per-click advertising, social media marketing, and various branding solutions. They cater to a diverse... Read More